300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Liberia
Norway
Malawi
Mexico
Nigeria
Tajikistan
Russian Federation
Togo
Tunisia
Nepal
Guinea
Haiti
Iran
Isle of Man
Madagascar
Lesotho
Pakistan
Puerto Rico
Romania
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Serbia
Uzbekistan
Panama
New Zealand
Australia
Morocco
Sri Lanka
Saudi Arabia
Switzerland
Guatemala
Kazakhstan
Jamaica
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Senegal
Sierra Leone
Tanzania
El Salvador
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Azerbaijan
Bulgaria
Ecuador
Estonia
Ethiopia
Faroe Islands
Jersey
Bahrain
Bahamas
Jordan
Bolivia
Belize
Algeria
Italy
Hungary
Finland
Belarus
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
FOCUS ASSET MANAGEMENT, VC Fund

FOCUS ASSET MANAGEMENT

VC Fund

Yeoksamdong, South Korea

FOCUS ASSET MANAGEMENT is a VC fund in Yeoksamdong focused on Health Care and Biotechnology. FOCUS ASSET MANAGEMENT provides recruiting and investment advisory services.

Total investments:
4
Last investment:
Lead investor:
0%

Last updated:

Industries FOCUS ASSET MANAGEMENT invests in

Health CareBiotechnologyMedicalGeneticsSoftware

Stages FOCUS ASSET MANAGEMENT invests in

Series CFunding RoundPost-IPO EquityConvertible Note

Countries FOCUS ASSET MANAGEMENT invests in

South Korea

Investment Focus

Industry

  • Health Care 2 (50%)
  • Biotechnology 2 (50%)
  • Medical 1 (25%)
  • Genetics 1 (25%)
  • Software 1 (25%)
See all 10 industries →

Stage

  • Series C 1 (25%)
  • Funding Round 1 (25%)
  • Post-IPO Equity 1 (25%)
  • Convertible Note 1 (25%)

Investments

CompanyDescriptionRoundLinks
Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. $10.8M / Post-IPO Equity / Apr 10, 2026
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. $15.4M / Convertible Note / Sep 29, 2022
Bertis is the AI-Driven proteomics for the Next Era of Precision Medicine. Bertis platform utilises molecular diagnostics to identify cancer-related biomarkers, enabling medical practitioners to detect diseases. $11.9M / Dec 28, 2020
Bertis is the AI-Driven proteomics for the Next Era of Precision Medicine. Bertis platform utilises molecular diagnostics to identify cancer-related biomarkers, enabling medical practitioners to detect diseases. $14.6M / Series C / Dec 28, 2020

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Liberia
Norway
Malawi
Mexico
Nigeria
Tajikistan
Russian Federation
Togo
Tunisia
Nepal
Guinea
Haiti
Iran
Isle of Man
Madagascar
Lesotho
Pakistan
Puerto Rico
Romania
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Serbia
Uzbekistan
Panama
New Zealand
Australia
Morocco
Sri Lanka
Saudi Arabia
Switzerland
Guatemala
Kazakhstan
Jamaica
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Senegal
Sierra Leone
Tanzania
El Salvador
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Azerbaijan
Bulgaria
Ecuador
Estonia
Ethiopia
Faroe Islands
Jersey
Bahrain
Bahamas
Jordan
Bolivia
Belize
Algeria
Italy
Hungary
Finland
Belarus
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does FOCUS ASSET MANAGEMENT invest in?

FOCUS ASSET MANAGEMENT invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did FOCUS ASSET MANAGEMENT last invest?

The most recent investment recorded for FOCUS ASSET MANAGEMENT closed in Apr 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
FOCUS ASSET MANAGEMENT FOCUS ASSET MANAGEMENT Find emails